decad
cation
polym
nanoparticl
investig
nucleic
acid
deliveri
despit
promis
vitro
transfect
result
formul
fail
translat
clinic
due
signific
vivo
toxic
especi
deliv
intraven
address
signific
problem
investig
detail
mechan
govern
complex
vivo
system
toxic
respons
common
polymer
nanoparticl
determin
toxic
respons
materi
depend
branch
polyethylenimin
bpei
nanoparticl
toxic
function
multipl
pathophysiolog
respons
trigger
innat
immun
sensor
induct
hepat
toxic
signific
alter
hematolog
properti
contrast
chitosanbas
nanoparticl
system
toxic
primarili
driven
innat
immun
activ
identifi
modif
primari
amin
secondari
tertiari
amin
use
small
molecul
imidazoleaceticacid
iaa
amelior
vivo
toxic
nanocarri
differ
materialspecif
mechan
relat
tolllik
receptor
activ
bpei
complement
activ
driven
neutrophil
infiltr
chitosan
respect
result
provid
detail
roadmap
evalu
vivo
toxic
nanocarri
identifi
potenti
opportun
reduc
toxic
eventu
clinic
translat
wide
varieti
nanoparticl
develop
past
decad
facilit
deliveri
nucleic
acidbas
therapi
plasmid
dna
oligonucleotid
shortinterf
rna
sirna
micro
rna
mirna
messeng
rna
mrna
form
nanoparticl
anion
nucleic
acid
often
complex
cation
polym
cation
lipid
process
result
nanoparticl
effici
nucleic
acid
load
favor
physic
characterist
intracellular
deliveri
cargo
vitro
despit
sever
desir
attribut
cation
nanoparticl
induc
signific
vivo
toxic
especi
deliv
system
prevent
clinic
translat
even
decad
research
lipidbas
particl
toxic
profil
improv
use
ioniz
neutral
lipid
excipi
fact
current
clinic
trial
system
deliveri
use
nanoparticl
use
lipidbas
particl
meanwhil
whole
class
materi
cation
polym
despit
demonstr
promis
vitro
efficaci
result
decad
advanc
clinic
case
nanoparticl
consist
modifi
cyclodextrin
protamin
evalu
phase
clinic
trial
studi
pursu
ideal
nucleic
acid
deliveri
agent
must
ensur
balanc
low
toxic
high
therapeut
efficaci
vivo
two
attribut
difficult
achiev
simultan
use
cation
polym
nanoparticl
chemist
materi
scientist
empir
optim
physicochem
properti
eg
size
surfac
function
group
charg
improv
nanoparticl
safeti
transfect
effici
studi
identifi
formul
lower
vitro
toxic
case
potenti
vivo
efficaci
anim
model
detail
studi
relationship
nanoparticl
design
mechan
vivo
system
toxic
scarc
limit
scope
wide
studi
modif
reduc
system
toxic
nanoparticl
addit
polyethylen
glycol
peg
formul
major
drawback
pegmodifi
formul
howev
antipeg
antibodi
gener
activ
complement
cascad
decreas
therapeut
efficaci
shortcom
peg
could
predict
vitro
highlight
import
studi
investig
detail
vivo
mechan
nanoparticl
induc
system
toxic
accur
predict
subsequ
minim
vivo
system
toxic
requir
critic
comprehens
understand
nanoparticl
interact
varieti
biolog
compon
vivo
deliveri
eg
serum
protein
blood
immun
cell
cell
variou
tissu
like
liver
lung
spleen
also
critic
understand
distribut
organ
specif
celltyp
trigger
innat
immun
respons
studi
identifi
distinct
contributor
vivo
toxic
respons
induc
two
widelyreport
cation
nanoparticl
nucleic
acid
deliveri
branch
polyethyleneimin
bpei
chitosan
found
mechan
vivo
system
toxic
combin
innat
immun
respons
complement
reaction
hepat
hematolog
toxic
rel
contribut
differ
type
polym
compar
vivo
system
toxic
nanoparticl
modif
small
molecul
imidazoleaceticacid
iaa
modifi
primaryamin
polym
introduc
secondari
tertiari
amin
hypothes
modif
would
reduc
innat
immun
activ
downregul
interact
tolllik
receptor
observ
reduc
system
toxic
iaamodifi
nanoparticl
also
observ
signific
impact
measur
system
toxic
respons
includ
vivo
hepatotox
complement
activ
chang
hematolog
properti
investig
vivo
system
toxic
knockout
mice
confirm
mechan
toxic
complet
result
indic
allevi
vivo
toxic
iaa
materialdepend
driven
uniqu
physiolog
pathway
observ
provid
valuabl
insight
vivo
immun
respons
cation
nanoparticl
nucleic
acid
deliveri
also
establish
detail
roadmap
better
understand
origin
vivo
system
toxic
nanoparticl
insight
gener
could
allow
ration
design
improv
cation
polym
formul
achiev
optim
balanc
toxic
efficaci
vivo
therebi
enabl
clinic
translat
anim
experi
conduct
accord
approv
iacuc
protocol
georgia
institut
technolog
emori
univers
shayakhmetov
lab
femal
week
old
mice
jackson
lab
bar
harbor
use
wildtyp
toxic
mrna
transfect
studi
femal
week
old
knockout
mice
jackson
lab
bar
harbor
use
knockout
studi
euthanasia
perform
confirm
cervic
disloc
unmodifi
bpei
nanoparticl
bpeitpp
iaamodifi
bpei
nanoparticl
bpeiiaatpp
produc
mix
solut
bpei
bpeiiaa
sodium
tripolyphosph
deioniz
water
mass
ratio
bpei
bpeiiaa
tpp
unmodifi
chitosan
nanoparticl
chitosantpp
iaamodifi
chitosan
nanoparticl
produc
mix
solut
chitosan
chitosaniaa
sodium
tripolyphosph
sodium
acet
buffer
ph
mass
ratio
chitosan
chitosaniaa
tpp
follow
vortex
nanoparticl
formul
put
onto
rotat
room
temperatur
minut
rotat
nanoparticl
centrifug
g
minut
amicon
centrifug
filter
kd
mwco
resuspend
ml
pb
size
zeta
potenti
particl
measur
use
malvern
zetas
nano
zs
fluoresc
label
bpei
chitosan
nanoparticl
react
hour
rotat
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
dark
unreact
dye
remov
centrifug
g
amicon
centrifug
filter
kd
mwco
fluoresc
nanoparticl
resuspend
ml
pb
prior
use
experi
mice
administ
mg
chitosankg
bodi
weight
mg
bpeikg
bodi
weight
iv
dose
nanoparticl
specifi
endpoint
mice
sacrif
blood
spleen
collect
blood
store
c
overnight
centrifug
g
minut
isol
serum
tnfa
elisa
perform
serum
sampl
use
supplement
egta
proteinas
inhibitor
triton
x
lysat
frozen
c
thaw
cell
debri
pellet
centrifug
g
minut
blot
spleen
lysat
prepar
proteom
profil
mous
cytokin
array
kit
panel
r
system
minneapoli
mn
use
establish
protocol
blot
develop
chemiluminesc
imag
perform
use
amersham
imag
ge
healthcar
uk
mice
administ
mg
bpeikg
mg
chitosankg
bodi
weight
iv
dose
nanoparticl
minut
minut
mice
sacrif
blood
collect
vial
lithium
heparin
gel
anticoagul
hematocrit
level
hemoglobin
concentr
neutrophil
fraction
white
blood
cell
measur
sysmex
xnl
autom
hematolog
analyz
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
raw
macrophag
seed
well
plate
densiti
cellswel
cell
treat
nanoparticl
minut
minut
cell
wash
three
time
pb
fix
paraformaldehyd
pb
minut
room
temperatur
permeabil
minut
room
temperatur
pla
perform
novu
dilut
tirap
novu
dilut
analyz
via
flow
cytometri
use
duolink
pla
flow
cytometri
kit
sigma
aldrich
st
loui
mo
sampl
analyz
use
bd
accuri
benchtop
cytomet
median
fluoresc
intens
report
bone
marrow
cell
harvest
mice
cell
differenti
dendrit
cell
use
mous
gmcsf
ngml
peprotech
rocki
hill
nj
nanoparticl
formul
administ
cell
hour
supernat
harvest
cytokin
level
tnfa
measur
use
luminex
assay
biotechn
minneapoli
mn
statist
analysi
perform
use
graphpad
prism
softwar
determin
statist
differ
two
group
normal
gaussian
distribut
student
ttest
twotail
unpair
unequ
varianc
p
perform
determin
statist
differ
signific
three
group
oneway
anova
perform
follow
posthoc
tukey
test
outlier
identifi
remov
use
grubb
test
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
investig
vivo
immun
respons
bpei
chitosan
nanoparticl
determin
iaa
modif
nanoparticl
would
alter
immun
respons
nanoparticl
formul
synthes
ionic
gelat
process
sodium
tripolyphosph
unmodifi
bpei
nanoparticl
bpeitpp
iaamodifi
bpei
nanoparticl
bpeiiaatpp
unmodifi
chitosan
nanoparticl
chtpp
iaamodifi
chitosan
nanoparticl
chiaatpp
fig
pei
chitosan
report
activ
macrophag
lead
secret
nitric
oxid
tumor
necrosi
factor
alpha
tnfa
addit
chitosan
trigger
dna
releas
mitochondria
vitro
result
stimulatorofinterferongen
sting
pathwaymedi
upregul
antivir
signal
product
interferon
proinflammatori
cytokin
hypothes
innat
immun
reaction
could
reduc
modif
primari
amin
polym
secondari
tertiari
amin
could
time
preserv
enhanc
buffer
capac
thu
deliveri
efficaci
achiev
conjug
iaa
bpei
chitosan
use
carbodiimid
chemistri
fig
use
nuclear
magnet
reson
spectroscopi
nmr
determin
avail
reaction
site
bpei
polym
modifi
iaa
supplementari
fig
nanoparticl
compos
unmodifi
iaamodifi
bpei
slightli
less
nm
size
supplementari
fig
unmodifi
iaamodifi
bpei
nanoparticl
similar
slightli
neg
zeta
potenti
mv
ph
quantifi
iaa
modif
chitosan
measur
absorb
spectrophotometri
nm
supplementari
fig
unmodifi
chitosan
nanoparticl
mean
diamet
nm
iaamodifi
chitosan
nanoparticl
slightli
wider
size
distribut
unmodifi
counterpart
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
sem
imag
suggest
due
aggreg
format
larger
nanoparticl
supplementari
fig
c
bpei
nanoparticl
iaa
modif
affect
zeta
potenti
chitosan
nanoparticl
formul
slightli
posit
zeta
potenti
mv
ph
evalu
system
toxic
cation
nanoparticl
intraven
iv
deliveri
administr
rout
associ
high
level
toxic
initi
vivo
experi
probe
serum
level
proinflammatori
cytokin
fig
detect
amount
tnfa
measur
vivo
administr
either
bpei
formul
unmodifi
chitosan
nanoparticl
induc
vivo
product
tnfa
behavior
evalu
mice
minut
iv
inject
support
serum
cytokin
alt
data
treat
unmodifi
chitosan
bpei
nanoparticl
mice
suffer
discomfort
lethargi
comparison
untreat
mice
mice
treat
iaamodifi
chitosan
bpei
nanoparticl
symptom
lethargi
reduc
next
evalu
iaa
modif
affect
bpei
nanoparticl
organ
biodistribut
immun
cell
activ
spleen
complement
activ
unmodifi
fluoresc
label
bpei
nanoparticl
accumul
liver
kidney
lung
one
hour
iv
inject
unmodifi
bpei
nanoparticl
remain
organ
hour
inject
iaamodifi
fluoresc
label
bpei
nanoparticl
local
organ
fewer
nanoparticl
present
organ
hour
inject
supplementari
fig
c
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
spleen
unmodifi
bpei
nanoparticl
increas
level
chemokin
cxc
motif
ligand
cxc
motif
ligand
cc
motif
ligand
spleen
fig
supplementari
fig
circul
monocyt
uptak
unmodifi
iaamodifi
bpei
nanoparticl
significantli
differ
one
hour
inject
fig
circul
neutrophil
uptak
unmodifi
bpei
nanoparticl
howev
found
time
higher
uptak
iaamodifi
bpei
nanoparticl
fig
complement
activ
measur
complement
level
serum
significantli
differ
mice
treat
unmodifi
iaamodifi
bpei
nanoparticl
fig
collect
blood
measur
level
serum
cytokin
observ
qualit
differ
blood
viscos
mice
treat
unmodifi
bpei
nanoparticl
inspir
us
evalu
cation
nanoparticl
influenc
blood
properti
iv
inject
minut
mice
treat
unmodifi
bpei
nanoparticl
hematocrit
rose
time
point
hemoglobin
concentr
rose
gdl
contrast
chang
hematocrit
hemoglobin
concentr
observ
iaamodifi
bpei
nanoparticletr
mice
minut
fig
unmodifi
iaamodifi
bpei
nanoparticl
increas
neutrophil
fraction
white
blood
cell
minut
neutrophil
fraction
remain
high
mice
treat
unmodifi
bpei
nanoparticl
minut
return
baselin
mice
treat
iaamodifi
bpei
nanoparticl
fig
increas
hematocrit
prompt
us
evalu
unmodifi
bpei
nanoparticl
initi
coagul
cascad
hemolyz
red
blood
cell
induc
adenosin
diphosph
releas
subsequ
activ
platelet
neither
bpei
nanoparticl
formul
induc
signific
amount
hemolysi
incub
whole
blood
concentr
twice
high
blood
pool
concentr
bpei
nanoparticl
immedi
iv
inject
experi
supplementari
fig
hypothes
high
hematocrit
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
could
attribut
fluid
extravas
result
enhanc
vascular
permeabl
follow
anaphylact
respons
histamin
level
howev
significantli
elev
minut
bpei
nanoparticl
inject
supplementari
fig
suggest
minim
role
anaphylaxi
associ
bpei
nanoparticl
final
assess
role
activ
vivo
toxic
measur
immun
respons
bpei
nanoparticl
knockout
mice
measur
product
measur
sera
knockout
mice
hour
supplementari
fig
alt
level
still
elev
supplementari
fig
indic
play
role
vivo
system
toxic
bpei
nanoparticl
sole
contributor
toxic
effect
perform
indepth
analysi
vivo
biodistribut
system
toxic
unmodifi
iaamodifi
chitosan
nanoparticl
iaamodifi
chitosan
nanoparticl
readili
intern
liver
kidney
lung
hour
moreov
nanoparticl
remain
insid
organ
hour
administr
supplementari
fig
although
iaamodifi
chitosan
nanoparticl
persist
longer
mice
continu
see
evid
reduc
vivo
system
toxic
iaamodifi
chitosan
instanc
iaa
modif
prevent
upregul
observ
spleen
mice
treat
unmodifi
chitosan
nanoparticl
hour
fig
supplementari
fig
unmodifi
chitosan
nanoparticl
ingest
circul
monocyt
iaamodifi
chitosan
nanoparticl
ingest
circul
monocyt
fig
curious
circul
neutrophil
uptak
chitosan
nanoparticl
agreement
vivo
organ
biodistribut
data
circul
neutrophil
ingest
unmodifi
chitosan
nanoparticl
nearli
circul
neutrophil
ingest
iaamodifi
chitosan
nanoparticl
fig
complement
level
mice
treat
iaamodifi
chitosan
nanoparticl
nearli
doubl
level
mice
treat
unmodifi
chitosan
nanoparticl
fig
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
unmodifi
chitosan
nanoparticl
induc
higher
level
hematocrit
hemoglobin
fig
unmodifi
iaamodifi
chitosan
nanoparticl
increas
neutrophil
level
blood
minut
fig
investig
surfac
unmodifi
iaamodifi
nanoparticl
chang
exposur
serum
protein
ex
vivo
mass
spectrometrybas
proteom
analysi
reveal
iaa
modif
bpei
chitosan
significantli
decreas
complement
adsorpt
typic
occur
incub
mous
plasma
one
hour
supplementari
fig
exclus
bpei
nanoparticl
iaa
modif
significantli
decreas
adsorpt
fibrinogen
protein
nanoparticl
surfac
supplementari
fig
data
suggest
evolut
protein
corona
depend
type
polym
eg
chitosan
bpei
polym
modifi
iaa
determin
vivo
system
toxic
could
predict
vitro
assay
evalu
innat
immun
respons
unmodifi
iaamodifi
bpei
nanoparticl
mous
bone
marrowderiv
dendrit
cell
bmdc
hypothes
iaa
modif
reduc
system
toxic
reduc
interact
perform
proxim
ligat
assay
measur
interact
tollinterleukin
receptor
domain
contain
adaptor
protein
tirap
essenti
signal
induc
proinflammatori
activ
inde
unmodifi
bpei
nanoparticl
trigger
signal
minut
iaamodifi
bpei
nanoparticl
fail
trigger
signal
fig
treatment
bmdc
unmodifi
bpei
nanoparticl
result
higher
secret
proinflammatori
cytokin
bmdc
treat
iaaall
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
modifi
bpei
nanoparticl
fig
signific
differ
tnfa
secret
observ
cell
treat
unmodifi
iaamodifi
bpei
nanoparticl
fig
endosom
escap
unmodifi
iaamodifi
bpei
nanoparticl
evalu
measur
coloc
intracellular
compart
earli
endosom
marker
lysosom
marker
clathrin
caveolin
hour
treatment
incomplet
overlap
intracellular
compart
observ
unmodifi
iaamodifi
nanoparticl
formul
supplementari
fig
indic
bpei
nanoparticl
regardless
iaa
modif
abl
escap
cytoplasm
facilit
deliveri
mrna
sirna
confirm
chang
innat
immun
activ
due
differ
cellular
uptak
bpei
iaamodifi
bpei
nanoparticl
supplementari
fig
test
iaa
modif
could
reduc
vitro
innat
immun
respons
chitosan
nanoparticl
first
evalu
uptak
unmodifi
iaamodifi
chitosan
nanoparticl
mous
endotheli
cell
mec
supplementari
fig
stark
differ
observ
chitosan
nanoparticl
uptak
iaa
modif
found
mec
intern
iaamodifi
chitosan
nanoparticl
hour
fewer
mec
intern
unmodifi
chitosan
nanoparticl
time
point
associ
higher
cellular
uptak
iaamodifi
chitosan
nanoparticl
inflammatori
mous
bmdc
unmodifi
chitosan
nanoparticl
signific
differ
level
secret
fig
secret
fig
tnfa
fig
level
elev
bmdc
treat
iaamodifi
chitosan
nanoparticl
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
end
goal
design
cation
nanoparticl
nucleic
acid
transfect
test
iaamodifi
bpei
chitosan
nanoparticl
could
transfect
sirna
gene
target
melanoma
cell
intrigu
therapeut
target
could
potenti
reduc
tumorrel
immun
suppress
first
induc
melanoma
cell
treatment
interferong
concentr
ngml
treatment
cell
unmodifi
bpei
chitosan
nanoparticl
yield
two
observ
first
nanoparticl
target
sirna
could
reduc
gene
express
rel
nanoparticl
neg
control
sirna
second
unmodifi
bpei
chitosan
nanoparticl
neg
control
sirna
upregul
express
cell
without
nanoparticl
iaamodifi
nanoparticl
neg
control
sirna
hand
upregul
express
sinc
upregul
respons
activ
data
support
iaa
modif
reduc
inflammatori
respons
cation
nanoparticl
supplementari
fig
also
evalu
bpei
nanoparticl
could
deliv
function
luciferas
mrna
mluc
first
deliv
mluc
bpei
nanoparticl
hela
cell
measur
luminesc
cell
lysat
hour
normal
luminesc
signal
iaamodifi
bpei
nanoparticletr
cell
mluc
four
time
higher
cell
treat
unmodifi
bpei
nanoparticl
mluc
supplementari
fig
follow
studi
evalu
iaamodifi
bpei
nanoparticl
could
deliv
function
mluc
vivo
three
hour
iv
deliveri
luciferas
mrna
observ
increas
bli
signal
lung
rel
untreat
mice
level
bli
signal
remain
high
hour
supplementari
fig
equival
dose
unmodifi
bpei
nanoparticl
caus
sever
acut
toxic
within
minut
luciferas
express
measur
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
primari
goal
studi
identifi
princip
driver
vivo
system
toxic
induc
two
commonli
studi
cation
polym
nanoparticl
branch
polyethylenimin
chitosan
tabl
evalu
convers
primari
amin
tertiari
amin
modif
iaa
could
mitig
vivo
system
toxic
prior
report
evalu
nanoparticl
toxic
measur
vitro
innat
immun
activ
ex
vivo
immun
cell
ex
vivo
complement
activ
serum
chang
protein
corona
ex
vivo
incub
serum
also
hand
studi
report
cation
polym
induc
vivo
innat
immun
respons
howev
comprehens
evalu
rel
contribut
hematolog
hepat
immun
reaction
overal
system
toxic
profil
cation
polym
nanoparticl
mechan
allevi
studi
although
research
evalu
effect
variou
small
molecul
modif
vitro
cytotox
cation
nanoparticl
effect
vivo
system
toxic
poorli
understood
result
address
sever
signific
gap
knowledg
use
chitosan
bpei
exemplar
cation
polym
iaa
exemplar
modif
reduc
primari
amin
content
increas
tertiari
amin
polym
discov
iaa
modif
could
inde
reduc
acut
system
toxic
respons
bpei
nanoparticl
vivo
system
toxic
induc
unmodifi
bpei
nanoparticl
domin
combin
chang
blood
properti
stimul
product
spleen
liver
toxic
measur
increas
alt
level
serum
fig
knowledg
first
report
identifi
cation
polym
nanoparticleinduc
chang
blood
properti
vivo
infer
sharp
increas
hematocrit
treatment
unmodifi
bpei
nanoparticl
associ
liver
toxic
studi
correl
heighten
level
alt
high
hematocrit
shown
increas
product
acut
phase
protein
suggest
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
chang
blood
properti
bpei
nanoparticl
administr
could
consequ
hepatocyt
damag
recruit
neutrophil
circul
aid
clear
unmodifi
bpei
nanoparticl
discoveri
heighten
liver
toxic
line
report
demonstr
express
hepatocyt
elev
hepatocyt
toxic
peicoat
gold
nanoparticl
peiinduc
impair
cellular
respir
liver
mitochondria
howev
result
system
toxic
knockout
mice
show
driver
hepat
toxic
bpei
nanoparticl
conclus
base
elimin
respons
alt
respons
inject
unmodifi
bpei
nanoparticl
knockout
mice
remark
iaa
abl
downregul
sever
biomark
vivo
system
toxic
bpei
nanoparticl
iaa
modif
reduc
liver
toxic
product
product
intraven
administr
reduc
toxic
may
attribut
chang
protein
corona
fibrinogen
bind
pei
nanoparticl
significantli
reduc
iaa
modif
fibrinogen
enhanc
innat
immun
activ
upregul
chemokin
express
observ
treatment
unmodifi
pei
nanoparticl
iaamodifi
pei
nanoparticl
reduc
toxic
could
attribut
chang
complement
activ
blood
hemolysi
anaphylact
respons
mediat
histamin
modif
chitosan
iaa
also
reduc
vivo
system
toxic
result
fascin
vivo
system
toxic
respons
unmodifi
chitosan
ident
respons
unmodifi
pei
vivo
system
toxic
respons
bpei
chitosan
share
elev
neutrophil
level
circul
level
serum
level
spleen
fig
howev
found
liver
toxic
chang
blood
properti
appear
play
major
role
drive
vivo
system
toxic
chitosan
chitosan
nanoparticl
also
increas
serum
level
tnfa
agreement
studi
demonstr
chitosan
activ
inflammasom
pathway
iaa
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
modif
prevent
upregul
chitosan
nanoparticleswhich
indic
bpei
iaa
reduc
innat
immun
activ
chitosan
time
iaa
modif
also
increas
neutrophil
uptak
chitosan
nanoparticl
vivo
complement
activ
seem
paradox
given
complement
activ
typic
consid
proinflammatori
complement
fragment
howev
shown
enhanc
antiinflammatori
activ
neutrophil
extracellular
trap
macrophag
evid
enhanc
neutrophil
uptak
heighten
complement
activ
reduc
enabl
plausibl
mechan
reduc
vivo
system
toxic
iaamodifi
chitosan
complex
phenomenon
multipl
cell
type
could
explain
dispar
vivo
vitro
toxic
result
chitosanwher
iaamodifi
chitosan
nanoparticl
induc
strong
innat
immun
respons
bmdc
toxic
evalu
vitro
intern
rate
nanoparticl
primari
driver
toxic
chitosan
known
activ
cga
sensor
cytosol
simplifi
vitro
screen
assay
take
consider
nanoparticl
intern
varieti
cell
vivo
potenti
effect
complement
respons
toxic
vitro
screen
assay
also
neglect
effect
acut
respons
one
cell
type
activ
feedback
mechan
cell
type
context
design
nanoparticl
nucleic
acid
deliveri
mismatch
vitro
cytotox
vivo
system
toxic
may
fals
elimin
viabl
nanoparticl
test
therefor
data
demonstr
thorough
vivo
toxic
analys
essenti
advanc
cation
polym
nanoparticl
nucleic
acid
deliveri
clinic
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
conclus
taken
togeth
find
illustr
vivo
system
toxic
regul
combin
differ
biolog
phenomena
tlr
activ
complement
activ
liver
toxic
chang
hematolog
contribut
biolog
phenomenon
cation
nanomateri
toxic
differ
differ
materi
bpei
toxic
profil
driven
liver
toxic
chang
hematolog
chitosan
toxic
profil
govern
balanc
tlr
complement
activ
classif
make
safe
nanoparticl
must
determin
weight
consider
vivo
biolog
phenomena
also
conclud
chemic
modif
affect
toxic
manner
appli
differ
polym
result
also
show
vitro
measur
innat
immun
respons
exampl
iaamodifi
chitosan
accur
predict
vivo
toxic
therefor
essenti
move
beyond
vitro
cytotox
screen
nanomateri
inform
detail
vivo
toxic
test
appropri
select
nanoparticl
candid
clinic
nucleic
acid
deliveri
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
raw
data
requir
reproduc
find
share
time
data
also
form
part
ongo
studi
process
data
requir
reproduc
find
share
time
data
also
form
part
ongo
studi
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
minut
bpei
nanoparticl
inject
outlier
identifi
remov
use
grubb
test
error
bar
repres
sd
mean
statist
differ
experi
two
group
determin
use
unpair
student
ttest
assum
unequ
varianc
statist
differ
experi
two
group
determin
use
oneway
anova
follow
tukey
test
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
bpei
nanoparticl
raw
macrophag
use
flow
cytometrybas
proxim
ligat
assay
outlier
identifi
remov
use
grubb
test
bg
mous
bmdc
treat
unmodifi
bpei
nanoparticl
bpeitpp
iaamodifi
bpei
nanoparticl
bpeiiaatpp
unmodifi
chitosan
nanoparticl
chtpp
iaamodifi
chitosan
nanoparticl
chiaatpp
cell
supernat
collect
tnfwere
measur
error
bar
repres
sd
mean
statist
differ
experi
two
group
determin
use
unpair
student
ttest
assum
unequ
varianc
statist
differ
experi
two
group
determin
use
oneway
anova
follow
tukey
test
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
